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Abstract In Europe the management of neurocysticercosis
(NCC) is challenging because health care providers are
unaware of this condition, thus leading to diagnostic delay
and mismanagement. The aim of this study is to retrospec-
tively review the cases of NCC observed in five centers
located in Florence, Negrar (Italy) and Barcelona (Spain). A
total of 81 subjects with NCC were evaluated in the period
1980–2013. By applying the Del Brutto’s criteria 39 cases
(48.1 %) were classified as definitive cases, 31 (38.8 %) as
probable cases and 11 (13.6 %) did not satisfy the diagnostic
criteria. Continent of originwas known for 80 subjects. Latin
America and Asia were the most frequent continents of
origin (n = 37; 46.3 % and n = 22; 27.5 %) followed by
Europe (n = 14; 17.5 %) and Africa (n = 7; 8.8 %). Com-
pared with adults, paediatric patients were more likely to
have eosinophilia, to have other parasitic infections, to be
asymptomatic, to not be treated with antiepileptic drugs or
analgesic and to heal. The study shows that there are some
hurdles in the management of NCC in Europe. A not negli-
gible portion of patients diagnosed at reference centers do
not fully satisfy Del Brutto’s diagnostic criteria. The higher
portion of asymptomatic subjects found among the paedi-
atric group is probably related to an ongoing serological
screening among adopted children coming from endemic
regions. The value of such a serological screening should be
better assessed by a further cost-effective analysis.
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Introduction
Cysticercosis/Taeniasis is listed among the so called
Neglected Tropical Diseases (NTD), which are a group of
17 diseases with distinct characteristics that thrive mainly
among the poorest populations [1]. Even though one of the
classical features of NTD is that they were restricted to
tropical and subtropical areas [2], the phenomenon of
international travel and migration make possible to observe
these diseases in temperate areas such as Europe [3].
Epidemiological data indicate that in Europe we are cur-
rently observing the overlapping between autochthonous
cases that are disappearing, and imported cases that are
rising as a consequence of travels and migrations [4].
The management of cysticercosis, and especially of
neurocysticercosis (NCC), the central nervous system
localization of the disease, is challenging in contexts where
the disease is not frequent and health care providers may be
unaware of this condition, thus leading to diagnostic delay
andmismanagement [4]. The aim of this study was to review
the cases of cysticercosis observed in fiveSouthernEuropean
tropical diseases centers and to compare the characteristic of
pediatric (\15 years) and adult patients.
Materials and methods
This is a retrospective observational study on cases of NCC
observed in five European centres located in 3 cities. The
participating centres are the Centre for Tropical Diseases
and the Paediatric department of Sacro Cuore-Don Cal-
abria Hospital, Negrar (Italy), the Infectious and Tropical
Diseases Unit, Azienda Ospedaliero-Universitaria Careggi
(AOUC), Florence (Italy), the Department for International
Adoptees and Immigrant Children, Infectious Diseases
Unit, Meyer Pediatric Hospital, Florence (Italy) and the
Hospital Clinic, Barcelona (Spain). All the five centres are
infectious diseases centres with inpatient and outpatient
facilities and services especially dedicated to the study and
management of tropical diseases in non endemic context.
The two pediatric centres offer a screening service for
adopted children for several infectious diseases including a
serological screening for cysticercosis as recommended by
an Italian protocol [5].
Clinical records of all patients with a diagnosis of cys-
ticercosis managed in the period 1980–2013 in everyone of
the participating centres were retrospectively reviewed.
The cases were retrieved with the help of clinical and lab
logs which are routinely compiled in each centres. The
diagnostic criteria proposed by Del Brutto et al. (Table 1,
[6]) have been retrospectively applied to each case.
Epidemiological and clinical data of each patient were
extracted from the clinical records using an anonymized and
standardized Epi InfoTM, version 3.5, 26th January, 2011.
Differences in categorical variables between adult and
pediatric cases were assessed using the Chi-square test
(p values\0.05 were considered significant).
Results
Eighty-one subjects with cysticercosis were evaluated at
the participating centers in the study period. All patients
had central nervous system localization of cysticercosis,
while extracerebral lesions were reported only in 1 patient.
By applying Del Brutto’s criteria [6] to assess the degree
of diagnostic certainty 39 cases (48.1 %) were classified as
definitive cases, 31 (38.8 %) as probable cases and 11
(13.6 %) were deemed to be cases of NCC even if the
diagnostic criteria were not fully satisfied. All patients
underwent at least a brain imaging. In detail 4 (4.9 %)
patients underwent CT scan only, 19 (23.4 %) MRI only
and 58 (71.6 %) both MRI and CT scan. Table 2 reports
the correlation between degree of diagnostic certainty, the
number and type of cerebral lesions and the positivity of
Enzyme-linked Immunoelectrotransfer Blot (EITB test) on
serum. The number of diagnoses by period and continent
of origin is reported in Fig. 1. Data on continent and
country of origin are reported in Table 3.
Among the 14 European subjects, 7 patients had a rel-
evant travel history to Latin America (3 cases), Sub-Sa-
haran Africa (2), East European countries (1), or unknown
country (1), while 7 cases were considered autochthonous
infections acquired in Spain (n = 6) or Italy (n = 1).
Among immigrants and adopted children, the time between
the arrival in the host country and the admission for NCC
was known in 58 cases. Of those, the majority (n = 32;
55.2 %) were admitted for NCC within 1–2 year after
arrival, 12 (20.7 %) 3–5 years after arrival, 10 (17.2 %)
6–10 years after arrival and 4 (6.9 %) more than 11 after
arrival (maximum delay 18 years).
Considering pediatric patients (n = 21), 10 (52.4 %)
were males and mean age was 5.8 years (range 1–15 years).
Among adult patients evaluated (n = 60), 23 (38.3 %) were
males and mean age was 37.7 years (range 15–81 years).
The mean age of European subjects without history of travel
(n = 7) was 59.7 years (range 32–81 years). Nine pediatric
patients (all asymptomatic and all adopted) were identified
on the basis of a serological screening (EITB) and underwent
subsequently to a brain MRI study showing lesions com-
patible with NCC.
Clinical features of patients are reported in Table 4.
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Discussion
The study shows several challenges related to the man-
agement of NCC in a non endemic area. In this multi-
center study, 81 NCC cases were only retrieved in a
33 years period with a peak in the first part of years 2000’,
probably due to the massive immigration from Latin
American countries observed in that period [7].
The epidemiological characteristics of the patients can help
to identify subjects with neurological signs or symptoms that
could be affected by NCC. For example, as already reported
[4], most NCC cases were imported from Latin America,
although cases from every continent have been observed.
Table 1 Diagnostic criteria for neurocysticercosis according to Del Brutto et al. [6]
Absolute 1. Histological demonstration of the parasite from biopsy of a brain or spinal cord lesion
2. Cystic lesions showing the scolex on CT or MRI
3. Direct visualization of subretinal parasites by funduscopic examination
Major 1. Lesions highly suggestive of neurocysticercosis on neuroimaging studiesa
2. Positive serum EITBb for the detection of anticysticercal antibodies
3. Resolution of intracranial cystic lesions after therapy with albendazole or praziquantel
4. Spontaneous resolution of small single enhancing lesionsc
Minor 1. Lesions compatible with neurocysticercosis on neuroimaging studiesd
2. Clinical manifestations suggestive of neurocysticercosise
3. Positive CSF ELISA for detection of anticysticercal antibodies or cysticercal antigens
4. Cysticercosis outside the CNSf
Epidemiological 1. Evidence of a household contact with Taenia solium infection
2. Individuals coming from or living in an area where cysticercosis is endemic
3. History of frequent travel to disease endemic areas
Degrees of certainty for the diagnosis of neurocysticercosis
Definitive 1. Presence of one absolute criterion
2. Presence of two major plus one minor and one epidemiologic criterion
Probable 1. Presence of one major plus two minor criteria
2. Presence of one major plus one minor and one epidemiologic criterion
3. Presence of three minor plus one epidemiologic criterion
The presence of two different lesions highly suggestive of neurocysticercosis on neuroimaging studies should be considered as two major
diagnostic criteria. However, positive results in two separate types of antibody detection tests should be interpreted only on the basis of the test
falling in the highest category of diagnostic criteria
a CT or MRI showing cystic lesions without scolex, enhancing lesions, or typical parenchymal brain calcifications
b Enzyme-linked immunoelectrotransfer blot assay using purified extracts of Taenia solium antigens, as developed by the Centers for Disease
Control and Prevention (Atlanta, GA)
c Solitary ring-enhancing lesions measuring less than 20 mm in diameter in patients presenting with seizures, a normal neurologic examination,
and no evidence of an active systemic disease
d CT or MRI showing hydrocephalus or abnormal enhancement of the leptomeninges, and myelograms showing multiple filling defects in the
column of contrast medium
e Seizures, focal neurologic signs, intracranial hypertension, and dementia
f Histologically confirmed subcutaneous or muscular cysticercosis, plain X-ray films showing ‘‘cigar-shaped’’ soft-tissue calcifications, or direct
visualization of cysticerci in the anterior chamber of the eye
ELISA enzyme-linked immunosorbent assay
Table 2 Correlation between the degree of diagnostic certainty
according to the Del Brutto’s criteria, number and type of cerebral
lesions and the positivity of Enzyme-linked Immunoelectrotransfer
Blot on serum in patients with neurocysticercosis
Degree of diagnostic certainty, number
and type of cerebral lesions
Rate of positivity of
EITB on serum
Single cerebral calcification 3/10 (30 %)
Multiple cerebral calcifications (C1) 5/13 (38.5 %)
Single non-calcified lesion 5/11 (45.5 %)
Multiple non-calcified lesions (C1) 12/19 (63.2 %)
Definitive diagnosis 22/31 (70.1 %)
Probable diagnosis 7/26 (26.9 %)
Non-sufficient criteria for diagnosis 5/11 (45.5 %)
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This study shows that there are some hurdles in the
diagnostic process of NCC. A non negligible portion of
patients (13.6 %) with a NCC diagnosis did not fully sat-
isfy Del Brutto’s diagnostic criteria. Moreover, 5.5 % of
patients underwent a biopsy-procedure, showing that non
invasive tools are not sufficient to achieve the diagnosis of
NCC or to rule out a CNS lesion of other origin. In our
cases-series, specific serology with EITB method in which
many clinicians rely for the diagnosis of NCC is shown to
be poorly sensitive with a positivity rate of 70.1 % in cases
with ‘‘definitive diagnosis’’.
In our study pediatric patients were less likely to have
symptoms. According to the literature there are several
differences among children and adults NCC cases. First of
all children are less frequently affected by NCC (Supple-
mentary references a–c) probably due to mechanisms
involved in disease acquisition and differences in the reac-
tivity of the immune system against the parasite (Supple-
mentary reference d). Autopsy series from several Mexico
City hospitals report a lower prevalence in children if
compared with adults (0.5 vs 2 %) [Supplementary refer-
ences e, f] and asymptomatic NCC detected with MRI is
found more often in subjects aged[15 years if compared
with those aged\15 years (Supplementary reference b). If
compared with children, adult patients with NCC have
usually higher incidence of headache (Supplementary ref-
erence d), extraparenchimal NCC (Supplementary refer-
ences d, g), raised intracranial pressure (Supplementary
references d, g), altered cerebrospinal fluid findings (Sup-
plementary references d), focal neurodeficits (Supplemen-
tary references g–i), depression syndrome (Supplementary
references g, j) and seizure recurrence after anticonvulsi-
vants discontinuation (Supplementary references g, k, l). On
the other hand children have more frequently seizures
(Supplementary reference d), single colloidal parenchymal
cysts (Supplementary reference d).
The high portion of asymptomatic cases of NCC in
children that we observed is probably related to the
ongoing serological screening for cysticercosis among
Fig. 1 Number of subjects
diagnosed with
neurocysticercosis by continent
of origin and year of diagnosis
Table 3 Continent and country of origin of subjects with diagnosis

























Unspecified African countries 2 2.5
Total 80 100
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Table 4 Clinical, serological and radiological features of subjects diagnosed with neurocysticercosis according to the age group (aged\15 years
and aged C15 years)
na/Nb (%)





Any symptoms related to cysticercosis 65/75 (86.7) 7/16 (43.7) 55/56 (98.2) 0.000
Epilepsy 40/65 (61.5) 6/7 (75) 32/55 (58.2) 0.159
Focal neurological deficit 9/65 (13.8) 0/7 (0) 8/55 (14.5) 0.279
Headache 8/65 (12.3) 0/7 (0) 8/55 (14.5) 0.279
Other neurological symptoms 8/65 (12.3) 1/7 (14.3) 7/55 (12.7) 0.907
Positive EITB on serum 34/68 (50.0) 13/20 (65.0) 21/48 (43.7) 0.110
Positive EIA on serum 2/7 (28.6) 1/3 (33.3) 1/4 (25.0) 0.809
Positive EITB or EIA on serum 36/69 (52.2) 14/20 (70.0) 22/49 (44.9) 0.058
Taenia solium taeniasis on parasitological stool examination 1/66 (1.5) 0/20 (0) 1/45 (2.2) 0.501
Positivity for any stool parasite 23d/66 (34.8) 11/20 (55) 12/45 (26.7) 0.027
Other parasitic infection 19e/58 (32.6) 10/19 (52.6) 9/39 (23.1) 0.024
Altered ‘‘fundus oculi’’ examination 3/34 (88.2) 0/6 (0) 3/27 (11.1) 0.391
Number of CNS lesions detected by brain CT scan and/or MRI
1 31/69 (44.9) 9/13 (69.2) 21/53 (39.6) 0.054
2–5 20/69 (29) 4/13 (30.8) 14/53 (26.4) 0.752
6–10 10/69 (14.5) 0/13 (0) 10/53 (18.8) 0.089
11–20 5/69 (7.2) 0/13 (0) 5/53 (9.4) 0.249
21–100 3/69 (4.3) 0/13 (0) 3/53 (5.6) 0.379
[100 0/69 (0) 0/13 (0) 0/53 (0) –
Type of CNS lesions
Cysts with scolex 4/72 (55.5) 0/15 (0) 4/54 (7.4) 0.295
Calcifications 32/72 (44.4) 9/15 (60) 22/54 (40.7) 0.184
Cysts without scolex 15/72 (20.8) 2/15 (13.3) 13/54 (24.1) 0.372
Enhancing lesions 28/72 (38.9) 6/15 (40) 20/54 (37) 0.824
Hydrocephalus 2/72 (2.8) 0/15 (0) 2/54 (3.7) 0.449
Intraventricular cysts 1/72 (1.4) 0/15 (0) 1/54 (1.8) 0.595
Diagnostic biopsy performed 4/73 (5.5) 0/16 (0) 4/54 (7.4) 0.262
Altered CSF 4f/14 (28.6) 0/0 (0) 4/14 (28.6) –
Altered EEG 13/40 (32.5) 5/7 (71.4) 7/32 (21.9) 0.010
Definitive case according to Del Brutto criteria 38/78 (48.7) 8/18 (44.4) 29/57 (50.9) 0.634
Probable case according to Del Brutto criteria 31/78 (39.7) 7/18 (38.9) 22/57 (38.6) 0.982
Del Brutto criteria not satisfied 9/78 (11.1) 3/18 (16.7) 6/57 (10.5) 0.484
Antiparasitic treatment performedg 64/77 (83.1) 13/18 (72.2) 50/57 (87.7) 0.117
Albendazole 53/63 (84.1) 13/13 (100) 40/49 (81.6) 0.094
Praziquantel 10/63 (15.9) 0/13 (0) 9/49 (18.4) 0.094
Multiple cycles of antiparasitic treatment 15/64 (23.4) 2/13 (15.4) 13/50 (26.0) 0.423
Treatment with corticosteroids 49/70 (70) 10/18 (55.5) 39/52 (75) 0.120
Treatment with antiepileptic drugs 48/74 (64.9)h,i 3/18 (16.7) 43/54 (79.6) 0.000
Treatment with analgesics 11/62 (17.7) 0/18 (0) 11/44 (25) 0.000
Surgical treatment 7/75 (9.3)l 0/18 7/56 (12.5) 0.114
Data on clinical follow-upm
Healed 7/33 (21.2) 4/6 (66.7) 3/27 (11.1) 0.013
Improved 15/33 (45.4) 1/6 (16.7) 14/27 (51.9) 0.266
Unchanged 10/33 (30.3) 1/6 (16.7) 9/27 (33.3) 0.754
Worsened 1/33 (3.0) 0/6 (0) 1/27 (3.7) 0.402
Data on radiological follow-up
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children adopted from endemic regions, which caused a not
negligible number of ‘‘only’’ seropositive children to be
evaluated for a possible NCC [5].
The screening for cysticercosis in asymptomatic sub-
jects could be theoretically useful in people at risk for NCC
in order to early intercept affected subjects and improve
their management and clinical outcome. However, there is
no clear evidence that treating an asymptomatic subject
harboring a live parasite will reduce the probability of
neurological symptoms in the future, so the usefulness of a
serological screening is questionable.
In conclusion, this study suggest that NCC is a rare
condition in Southern Europe, therefore it is not surprising
that clinicians may be poorly experienced in the diagnosis
and management of it. NCC should be included in the
differential diagnosis of patients with neurological signs or
symptoms, especially if coming from endemic countries.
Available diagnostic tools are not sufficiently accurate in
some cases and as a consequence, a definitive diagnosis
based on Del Brutto’s criteria cannot always be reached.
Moreover, the treatment should be tailored on a case-by-
case basis. For this reason, European health care providers
might benefit from a transfer of knowledge from colleagues
working in endemic areas through the creation of
international networks involving expert from endemic
areas. The development of a consensus diagnostic proce-
dures and therapeutic decisions would positively impact on
the patient care in Europe.
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